| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.511 | 0.003 | 0.511 | HIV-1 protease inhibitor | 0.343 0.003 DBMET03069 0.496 0.003 DBMET03070 0.477 0.003 DBMET03071 | ||
| 0.421 | 0.002 | 0.421 | Plasmepsin II inhibitor | 0.128 0.004 DBMET03069 0.135 0.003 DBMET03070 0.314 0.002 DBMET03071 | ||
| 0.441 | 0.022 | 0.452 | Cardiotonic | 0.339 0.042 DBMET03069 0.357 0.037 DBMET03070 0.452 0.02 DBMET03071 | DBMET03071 | |
| 0.307 | 0.005 | 0.307 | Protease inhibitor | 0.256 0.008 DBMET03069 0.263 0.007 DBMET03070 0.291 0.005 DBMET03071 | ||
| 0.273 | 0.106 | 0.275 | Apoptosis antagonist | 0.275 0.104 DBMET03069 0.265 0.113 DBMET03070 0.265 0.113 DBMET03071 | DBMET03069 | |
| 0.152 | 0.008 | 0.152 | Cathepsin D inhibitor | 0.122 0.012 DBMET03069 0.126 0.011 DBMET03070 0.147 0.008 DBMET03071 | ||
| 0.245 | 0.125 | 0.291 | Interleukin 2 agonist | 0.229 0.144 DBMET03069 0.229 0.144 DBMET03070 0.291 0.08 DBMET03071 | DBMET03071 | |
| 0.186 | 0.074 | 0.186 | P-glycoprotein inhibitor | 0.145 0.124 DBMET03070 0.174 0.085 DBMET03071 | ||
| 0.243 | 0.141 | 0.243 | Vasodilator, coronary | 0.208 0.174 DBMET03071 | ||
| 0.145 | 0.05 | 0.145 | Proteasome inhibitor | 0.097 0.092 DBMET03069 0.144 0.05 DBMET03071 | ||
| 0.101 | 0.006 | 0.101 | Renin inhibitor | 0.067 0.011 DBMET03069 0.068 0.011 DBMET03070 0.087 0.007 DBMET03071 | ||
| 0.207 | 0.115 | 0.207 | 5 Hydroxytryptamine release stimulant | |||
| 0.232 | 0.142 | 0.346 | Vasodilator, peripheral | 0.346 0.076 DBMET03069 0.23 0.144 DBMET03070 0.199 0.178 DBMET03071 | DBMET03069 | |
| 0.097 | 0.02 | 0.097 | Secretase beta inhibitor | 0.086 0.029 DBMET03071 | ||
| 0.116 | 0.039 | 0.116 | Interleukin 1 beta converting enzyme inhibitor | 0.097 0.061 DBMET03070 0.112 0.043 DBMET03071 | ||
| 0.087 | 0.019 | 0.087 | Cathepsin E inhibitor | 0.076 0.025 DBMET03069 0.077 0.024 DBMET03070 0.084 0.02 DBMET03071 | ||
| 0.064 | 0.016 | 0.074 | Macrophage elastase inhibitor | 0.041 0.032 DBMET03069 0.053 0.022 DBMET03070 0.074 0.013 DBMET03071 | DBMET03071 | |
| 0.092 | 0.044 | 0.092 | 3C-Like protease (SARS coronavirus) inhibitor | 0.08 0.067 DBMET03069 0.083 0.061 DBMET03071 | ||
| 0.179 | 0.133 | 0.181 | Immunostimulant | 0.181 0.132 DBMET03071 | DBMET03071 | |
| 0.115 | 0.069 | 0.115 | Cell adhesion inhibitor | 0.1 0.09 DBMET03071 | ||
| 0.14 | 0.095 | 0.143 | Growth hormone agonist | 0.126 0.111 DBMET03070 0.143 0.093 DBMET03071 | DBMET03071 | |
| 0.072 | 0.027 | 0.072 | Human rhinovirus A protease inhibitor | 0.06 0.035 DBMET03069 0.056 0.037 DBMET03070 0.067 0.03 DBMET03071 | ||
| 0.201 | 0.157 | 0.201 | Nootropic | |||
| 0.045 | 0.01 | 0.045 | Plasmepsin I inhibitor | 0.038 0.014 DBMET03069 0.039 0.013 DBMET03070 0.045 0.01 DBMET03071 | ||
| 0.174 | 0.139 | 0.19 | Peptidyltransferase inhibitor | 0.19 0.112 DBMET03069 0.19 0.112 DBMET03070 0.19 0.112 DBMET03071 | DBMET03071 | |
| 0.101 | 0.067 | 0.105 | Factor V inhibitor | 0.093 0.087 DBMET03069 0.095 0.082 DBMET03070 0.105 0.058 DBMET03071 | DBMET03071 | |
| 0.15 | 0.116 | 0.178 | Psychostimulant | 0.178 0.094 DBMET03069 0.137 0.128 DBMET03071 | DBMET03069 | |
| 0.043 | 0.01 | 0.043 | GHS receptor antagonist | 0.033 0.02 DBMET03069 0.033 0.021 DBMET03070 0.039 0.013 DBMET03071 | ||
| 0.099 | 0.067 | 0.129 | Nav1.1 sodium channel blocker | 0.115 0.052 DBMET03069 0.129 0.043 DBMET03070 0.114 0.053 DBMET03071 | DBMET03070 | |
| 0.108 | 0.079 | 0.108 | Caspase 3 inhibitor | 0.103 0.088 DBMET03071 | ||
| 0.045 | 0.019 | 0.045 | Sphingosine 1-phosphate receptor 3 agonist | 0.029 0.027 DBMET03069 0.03 0.027 DBMET03070 0.042 0.02 DBMET03071 | ||
| 0.045 | 0.02 | 0.045 | Growth hormone secretagogue receptor antagonist | 0.033 0.026 DBMET03071 | ||
| 0.087 | 0.065 | 0.087 | Antiadrenergic | |||
| 0.084 | 0.065 | 0.084 | Adrenaline antagonist | |||
| 0.063 | 0.044 | 0.063 | Nitric oxide donor | |||
| 0.026 | 0.013 | 0.026 | Neutral endopeptidase inhibitor | 0.023 0.014 DBMET03071 | ||
| 0.095 | 0.085 | 0.11 | Nav1.4 sodium channel blocker | 0.109 0.064 DBMET03069 0.11 0.063 DBMET03070 0.093 0.087 DBMET03071 | DBMET03070 | |
| 0.073 | 0.065 | 0.073 | Cell adhesion molecule inhibitor | |||
| 0.058 | 0.056 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.054 DBMET03069 | DBMET03069 | |
| 0.037 | 0.035 | 0.042 | Neurokinin 2 agonist | 0.042 0.028 DBMET03071 | DBMET03071 | |
| 0.214 | 0.251 | 0.248 | Calcium channel L-type activator | 0.248 0.207 DBMET03071 | DBMET03071 | |
| 0.06 | 0.099 | 0.084 | Chymotrypsin inhibitor | 0.084 0.049 DBMET03069 0.082 0.052 DBMET03070 | DBMET03069 | |
| 0.131 | 0.187 | 0.214 | Vasodilator | 0.214 0.094 DBMET03069 | DBMET03069 | |
| 0.031 | 0.095 | 0.056 | Elastase inhibitor | 0.056 0.034 DBMET03070 | DBMET03070 | |
| 0.08 | 0.256 | 0.167 | Hypolipemic | 0.167 0.121 DBMET03069 | DBMET03069 | |
| 0.009 | 0.191 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET03069 0.035 0.006 DBMET03070 | DBMET03070 | |
| 0.009 | 0.277 | 0.039 | Nicotinic receptor beta4 subunit antagonist | 0.039 0.024 DBMET03069 0.039 0.024 DBMET03070 | DBMET03070 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |